How An Optimized Purification Platform Can Speed mAbs Clinical Production

Getting your antibody to clinical trials faster while being able to build a robust, scalable, and high-yielding process is a challenge many biotech companies face. By outsourcing to a CTDMO, you can benefit from an optimized platform process.

In this webinar, we showcase our purification development platform, including an MMC* chromatography step and how it allowed our client, Igyxos Biotherapeutics, to simplify and accelerate their clinical trial supply while achieving high-quality material.

*mixed-mode chromatography

Learn how a process platform can help:

• Accelerate your development journey
• Facilitate transfer and scale-up to production
• Gain knowledge on the molecule